Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players
- Language: English
- 97 Pages
- Published: April 2013
- Region: Japan
Having displayed fluctuating growth rates in the years 2005-2009 the Japan pharmaceuticals market is expected to decelerate in 2010 follow by the slightly fluctuating growth rates over the years up to 2014.
The Japan pharmaceuticals market generated total revenues of $66,889.3 million in 2005, representing a compound annual growth rate (CAGR) of 2.3% for the period spanning 2005-2009. In comparison, the Chinese and Indian markets grew with CAGRs of 20.1% and 11.3% respectively, over the same period, to reach respective values of $23,796.9 million and $10,838.7 million in 2009.
Cardiovascular sales proved the most lucrative for the Japan pharmaceuticals market in 2009, generating total revenues of $14,104.6 million, equivalent to 21.1% of the market's overall value. In comparison, alimentary/metabolism sales generated revenues of $9,269.8 million in 2009, equating to 13.9% of the market's aggregate revenues.
This report highlights the Japan pharmaceutical sector in terms of market share, key trends, market players and competitive scenario in the market.
- Current market scenario of Japan pharmaceutical market, by revenue, geographic regions, product types, and market players.
- Competitive analysis of the pharmaceutical sector by each country via-a-vis global market
- Market forecast of Japan Pharmaceuticals market, by revenue till 2014.
- Covered more than 9 company profiles in the pharmaceutical sector covering their performance, key financials, SWOT analysis, and investment analysis.
Venn Research, in association to its network of partners provides information and research to thousands of clients worldwide. The information provided herein has been obtained from reliable sources to provide a holistic survey on the market dynamics. SHOW LESS READ MORE >
1 Japan Pharmaceuticals Market, 2010
1.1 Quick Glance at the Market
1.2 Market Scenario
2 Japan Pharmaceuticals Market, By Categories, 2010
3 Japan Pharmaceuticals Market, By Market Players, 2010
4 Japan Pharmaceuticals Market Outlook, 2011-2014
5 Japan Pharmaceuticals Market - Competitive Analysis
6 Company Profiles
6.1 Astellas Pharma
6.1.1 Key Financials
6.1.4 Products And Services Analysis:
6.1.5 SWOT Analysis
6.1.6 Company View
6.2 Daiichi Sankyo Co., Ltd.
6.2.1 Key Financials
6.2.4 Products and Services Analysis
6.2.5 Competitor Analysis
6.2.6 SWOT Analysis
6.3 Pfizer Inc
6.3.1 Key Financials
6.3.4 Products and Services Analysis
6.3.5 Competitor Analysis
6.3.6 SWOT Analysis
6.4 Jiangsu Yangtze River Pharmaceutical Group
6.5 Yung Shin Pharmaceutical Industry Co., Ltd.
6.6 ScinoPharm Taiwan, LTD.
6.6.2 Competitors Analysis
6.7 Cipla Ltd
6.7.3 Competitor Analysis
6.8 Piramal Healthcare (PHL)
6.8.3 Competitor Analysis
6.8.4 Investment Analysis
6.9 Ranbaxy Laboratories Limited
6.9.3 Products and Services Analysis
6.9.4 Competitor Analysis
6.9.5 SWOT Analysis
List of Tables:
Table 1: Japan Pharmaceuticals Market Outlook, ($ Billions) 2005 -2010
Table 2: Japan Pharmaceuticals Market, By Categories, 2010
Table 3: Japan Pharmaceuticals Market, By Market Players, 2010
Table 4: Japan Pharmaceuticals Market Outlook, ($ Billions) 2011 -2014
Table 5: Astellas Pharma - Key Financials, 2008-2010
Table 6: Astellas Pharma - Historical Stock Information
Table 7: Astellas Pharma Sales, By Geography
Table 8: Astellas Pharma Sales, By Products
Table 9: Daiichi Sankyo Co., Ltd. - Key Financials
Table 10: Daiichi Sankyo Co., Ltd. Sales, By Geography
Table 11: Pfizer Inc - Key Financials, 2007-09
Table 12: Pfizer Inc - Historical Stock Information
Table 13: Pfizer Inc Sales, By Products and Services, 2009
Table 14: Pfizer Inc Sales, By Geography, 2009
Table 15: Jiangsu Yangtze River Pharmaceutical Group - Key Financials
Table 16: Yung Shin Pharmaceutical Industry Co., Ltd. - Key Financials
Table 17: Cipla Ltd Sales, By Geography
Table 18: Piramal Healthcare Limited, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2010
Table 19: Piramal Healthcare Limited, Pharmaceuticals & Healthcare Deals By Type, 2005 to YTD 2010
Table 20: Ranbaxy Laboratories Limited Sles, By Georaphy, 2008
List of Figures:
Figure 1: Japan Pharmaceuticals Market Outlook, ($ Billions) 2005 -2010
Figure 2: Japan Pharmaceuticals Market, By Categories, 2010
Figure 3: Japan Pharmaceuticals Market, By Market Players, 2010
Figure 4: Japan Pharmaceuticals Market Outlook, ($ Billions) 2011 -2014
Daiichi Sankyo Co., Ltd.
Jiangsu Yangtze River Pharmaceutical Group
Yung Shin Pharmaceutical Industry Co., Ltd.
ScinoPharm Taiwan, LTD.
Ranbaxy Laboratories Limited
Piramal Healthcare (PHL)